Department of Internal Medicine II, University of Yamanashi, Faculty of Medicine.
J Atheroscler Thromb. 2019 Dec 1;26(12):1062-1074. doi: 10.5551/jat.48249. Epub 2019 Apr 16.
Although coronary endothelial vasomotor dysfunction predicts future coronary events, there are few human studies showing the relationship between endothelial vasomotor dysfunction and atheroma plaque progression in the same coronary artery. This study examined whether endothelial vasomotor dysfunction is related to atheroma plaque progression in the infarct-related coronary artery of ST-segment elevation myocardial infarction (STEMI) survivors using serial assessment of coronary plaque size with intravascular ultrasound (IVUS) and coronary vasomotor responses to acetylcholine (ACh).
This study included 50 patients with a first acute STEMI due to occlusion of the left anterior descending coronary artery (LAD) and successful reperfusion therapy with percutaneous coronary intervention (PCI). IVUS and vasomotor response to ACh in the LAD were measured within two weeks of acute myocardial infarction (AMI) (1 test) and repeated six months (2 test) after AMI under optimal anti-atherosclerotic therapies.
Percent atheroma volume (PAV) and total atheroma volume (TAV) in the LAD progressed over six months of follow-up in 18 and 14 patients, respectively. PAV and TAV progression was significantly associated with persistent impairment of epicardial coronary artery dilation and coronary blood flow increase in response to ACh at both the 1 and 2 tests. PAV and TAV progression had no significant association with traditional risk factors, PCI-related variables, medications, and the coronary vasomotor responses to sodium nitroprusside, an endothelium-independent vasodilator.
Persistent impairment of endothelial vasomotor function in the conduit arterial segment and the resistance arteriole was related to atheromatous plaque progression in the infarct-related coronary arteries of STEMI survivors.
尽管冠状动脉内皮血管舒缩功能障碍可预测未来的冠状动脉事件,但很少有研究表明同一冠状动脉内皮血管舒缩功能障碍与动脉粥样硬化斑块进展之间的关系。本研究通过血管内超声(IVUS)连续评估斑块大小和乙酰胆碱(ACh)诱导的冠状动脉血管舒缩反应,探讨了 ST 段抬高型心肌梗死(STEMI)幸存者梗死后相关冠状动脉内皮血管舒缩功能障碍与动脉粥样硬化斑块进展的关系。
本研究纳入了 50 例因左前降支(LAD)闭塞导致首次急性 STEMI 的患者,这些患者均接受了经皮冠状动脉介入治疗(PCI)成功再灌注治疗。在急性心肌梗死(AMI)后两周内(1 次测试)和 AMI 后 6 个月(2 次测试),在最佳抗动脉粥样硬化治疗下,测量 LAD 的 IVUS 和 ACh 诱导的血管舒缩反应。
在 6 个月的随访中,18 例患者的 LAD 内斑块百分比体积(PAV)和总斑块体积(TAV)进展,14 例患者的 PAV 和 TAV 进展。在 1 次和 2 次测试中,PAV 和 TAV 的进展均与 ACh 诱导的冠脉扩张和冠脉血流增加持续受损显著相关。PAV 和 TAV 的进展与传统危险因素、PCI 相关变量、药物以及内皮非依赖性血管扩张剂硝普钠诱导的冠脉血管舒缩反应无显著相关性。
在 STEMI 幸存者的梗死相关冠状动脉中,传导动脉段和阻力小动脉的内皮血管舒缩功能持续受损与动脉粥样硬化斑块进展有关。